Insider Transactions in Q1 2023 at Aquestive Therapeutics, Inc. (AQST)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2023
|
Stephen Wargacki Chief Science Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,981
-1.24%
|
$0
$0.79 P/Share
|
|
Mar 10
2023
|
Cassie Jung Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,365
-0.93%
|
-
|
|
Mar 09
2023
|
A Ernest Toth Jr SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
140,000
+50.0%
|
-
|
|
Mar 09
2023
|
Stephen Wargacki Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
135,000
+45.46%
|
-
|
|
Mar 09
2023
|
Lori J Braender SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+44.28%
|
-
|
|
Mar 09
2023
|
Daniel Barber President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
447,000
+41.1%
|
-
|
|
Mar 09
2023
|
Alexander Mark Schobel Chief Innovation/Tech Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+9.23%
|
-
|
|
Mar 09
2023
|
Cassie Jung Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
110,000
+42.84%
|
-
|
|
Mar 09
2023
|
Ken W. Marshall SVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+50.0%
|
-
|
|
Mar 09
2023
|
Peter E. Boyd See Remark |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+38.53%
|
-
|